- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Severe Haemophilia A With Inhibitors in New Zealand
Total 197 results
-
Baxalta now part of ShireCompletedAcquired Hemophilia AUnited States, Canada, India, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Germany, Switzerland, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Japan, Denmark, Hungary, Israel, Turkey, Russian Federation, Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BUnited States, Netherlands, Austria, Spain, Germany, Macedonia, The Former Yugoslav Republic of, Taiwan, United Kingdom, Italy, Malaysia, Thailand, France, Greece, Turkey, Japan, South Africa, Romania
-
Catalyst BiosciencesCompletedHemophilia AUnited States, Belgium, Hungary, Italy, New Zealand, South Africa, Turkey, United Kingdom
-
Grifols Therapeutics LLCGrifols Biologicals, LLCTerminatedHemophilia A, CongenitalUnited States, Spain, Italy, India, Canada, Russian Federation
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BUnited States, Netherlands, Germany, Macedonia, The Former Yugoslav Republic of, United Kingdom, Italy, Malaysia, Hungary, Thailand, France, Russian Federation, Turkey, Japan, South Africa, Canada
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia BUnited States, Italy, Ireland, New Zealand, United Kingdom, Australia, Netherlands, Denmark, Poland, Sweden, France
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia AUnited States, New Zealand, Australia, Hungary, Sweden, Austria, Poland, Romania
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia APoland, Belgium, France, Italy, Spain, United States, Australia, Netherlands, New Zealand, Sweden, Germany, Finland, Hungary
-
Englewood Hospital and Medical CenterMedtronicCompletedUtility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillatorsPatients With a Generation 2 Medtronic Implantable Cardioverter-defibrillator(ICD)United States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BSpain, United Kingdom, Australia, Taiwan, France, Malaysia, United States, Austria, Canada, Israel, Japan, Thailand, Algeria, Argentina
-
Green Cross CorporationAtlantic Research GroupUnknownHemophilia AUnited States, Canada, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
-
BayerCompletedHemophilia A, CongenitalSlovenia, Italy, Germany, France, United States, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan
-
CSL BehringRecruiting
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
American Thrombosis and Hemostasis NetworkBioMarin PharmaceuticalCompletedLiver Transplantation | Hemophilia A and BUnited States
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AKorea, Republic of, United States, France, Germany, Italy, South Africa, Spain, Japan, United Kingdom, Poland, Taiwan, Australia, Costa Rica, New Zealand
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Green Cross CorporationAtlantic Research GroupUnknown
-
PfizerCompletedHemophilia AUnited States, Argentina, Austria, Colombia, Croatia, Jordan, Mexico, New Zealand, Oman, Peru, Poland, Romania, Turkey
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Spark TherapeuticsChildren's Hospital of Philadelphia; University of Pittsburgh; St. James's Hospital... and other collaboratorsTerminated
-
BayerCompleted
-
Spark TherapeuticsCompletedHematologic Diseases | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Gene Therapy | Blood Coagulation Disorder | Gene Transfer | Adeno-Associated Virus (AAV) | Factor VIII (FVIII) | Factor VIII (FVIII)... and other conditionsUnited States
-
University of MiamiShireTerminated
-
Weill Medical College of Cornell UniversityUniversity of Pennsylvania; CSL BehringCompletedHemophilia A | Hemophilia BUnited States, Puerto Rico
-
New York Presbyterian HospitalCompletedHemophilia A | Hemophilia BUnited States
-
Northwell HealthNational Cancer Institute (NCI); University of California, San DiegoCompletedHemophilia A | Hemophilia B | HemarthrosesUnited States
-
Montefiore Medical CenterGenentech, Inc.Not yet recruitingHemophilia AUnited States
-
PfizerCompletedHemophilia BUnited States, Spain, Croatia, Serbia, Russian Federation, Canada, Hungary, Italy, Romania
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Completed
-
Healthcare Innovation Technology LabBayerUnknown
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Sintesi Research SrlUnknown
-
OctapharmaCompletedHemophilia AUnited States, Germany, Bulgaria
-
Baxalta now part of ShireCompletedHemophilia BRussian Federation, Ukraine, India, Poland, Romania, United Kingdom
-
Tulane UniversityGenentech, Inc.Recruiting
-
Baxalta now part of ShireCompleted
-
Genentech, Inc.Terminated
-
BayerAmerican Thrombosis and Hemostasis NetworkTerminated
-
BayerCompleted
-
Weill Medical College of Cornell UniversityBayer; University Hospital, BonnCompletedHemophilia A | Hemophilia BUnited States, Israel, Australia, Italy, Sweden, Germany, Japan, Netherlands, Taiwan
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
Genentech, Inc.Approved for marketingHemophilia AUnited States
-
Baxalta now part of ShireCompletedHemophilia AUnited States
-
BayerActive, not recruitingHemophilia ACanada, Spain, United States, Belgium, Italy, Taiwan, Slovenia
-
Baxalta now part of ShireBaxter BioScienceCompleted